GE HealthCare and Mayo Clinic aim to advance personalized cancer treatment through new theranostics research collaboration
Go back to GE HealthCare and Mayo Clinic aim to advance personalized cancer treatment through new theranostics research collaboration| (NASDAQ: GEHC) | Delayed: 61.41 -0.63 (1.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.04 | 52 Week High | $ | |||
| Open | $62.39 | 52 Week Low | $ | |||
| Day High | $62.70 | P/E | N/A | |||
| Day Low | $61.34 | EPS | $ | |||
| Volume | 3,057,769 | |||||

